nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—OPRL1—brainstem—narcolepsy	0.0242	0.167	CbGeAlD
Buprenorphine—OPRL1—forebrain—narcolepsy	0.0234	0.161	CbGeAlD
Buprenorphine—OPRD1—forebrain—narcolepsy	0.012	0.0829	CbGeAlD
Buprenorphine—OPRK1—forebrain—narcolepsy	0.0116	0.0795	CbGeAlD
Buprenorphine—OPRL1—brain—narcolepsy	0.0097	0.0668	CbGeAlD
Buprenorphine—OPRM1—brainstem—narcolepsy	0.00851	0.0586	CbGeAlD
Buprenorphine—OPRM1—forebrain—narcolepsy	0.00822	0.0565	CbGeAlD
Buprenorphine—OPRM1—midbrain—narcolepsy	0.00543	0.0373	CbGeAlD
Buprenorphine—OPRD1—brain—narcolepsy	0.005	0.0344	CbGeAlD
Buprenorphine—OPRK1—brain—narcolepsy	0.00479	0.033	CbGeAlD
Buprenorphine—OPRD1—Peptide ligand-binding receptors—TRH—narcolepsy	0.00441	0.00515	CbGpPWpGaD
Buprenorphine—OPRD1—G alpha (i) signalling events—PENK—narcolepsy	0.00437	0.00511	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—HCRTR1—narcolepsy	0.00435	0.00509	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—HCRTR2—narcolepsy	0.00435	0.00509	CbGpPWpGaD
Buprenorphine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1B—narcolepsy	0.00433	0.00506	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—HCRT—narcolepsy	0.00431	0.00504	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—P2RY11—narcolepsy	0.0042	0.00491	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00416	0.00487	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00416	0.00487	CbGpPWpGaD
Buprenorphine—OPRM1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00411	0.00481	CbGpPWpGaD
Buprenorphine—OPRM1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00411	0.00481	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00402	0.0047	CbGpPWpGaD
Buprenorphine—OPRM1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00397	0.00464	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—HCRT—narcolepsy	0.00393	0.0046	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0039	0.00456	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide ligand-binding receptors—TRH—narcolepsy	0.00386	0.00452	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—PENK—narcolepsy	0.00384	0.00449	CbGpPWpGaD
Buprenorphine—OPRK1—G alpha (i) signalling events—PENK—narcolepsy	0.00383	0.00448	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR ligand binding—NPS—narcolepsy	0.00383	0.00448	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR ligand binding—TAC1—narcolepsy	0.00383	0.00448	CbGpPWpGaD
Buprenorphine—CYP2A6—brain—narcolepsy	0.00365	0.0251	CbGeAlD
Buprenorphine—OPRD1—GPCR ligand binding—HCRTR1—narcolepsy	0.00362	0.00423	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—HCRTR2—narcolepsy	0.00362	0.00423	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—HCRT—narcolepsy	0.00357	0.00418	CbGpPWpGaD
Buprenorphine—OPRL1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00353	0.00413	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00352	0.00412	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00352	0.00412	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—PENK—narcolepsy	0.0035	0.0041	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—P2RY11—narcolepsy	0.00349	0.00409	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00348	0.00407	CbGpPWpGaD
Buprenorphine—ABCG2—medulla oblongata—narcolepsy	0.00347	0.0239	CbGeAlD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00342	0.004	CbGpPWpGaD
Buprenorphine—CYP2D6—brainstem—narcolepsy	0.00341	0.0235	CbGeAlD
Buprenorphine—OPRM1—brain—narcolepsy	0.00341	0.0235	CbGeAlD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0034	0.00398	CbGpPWpGaD
Buprenorphine—CYP2D6—forebrain—narcolepsy	0.00329	0.0227	CbGeAlD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—TRH—narcolepsy	0.00326	0.00382	CbGpPWpGaD
Buprenorphine—OPRD1—G alpha (i) signalling events—HRH3—narcolepsy	0.00326	0.00381	CbGpPWpGaD
Buprenorphine—OPRM1—G alpha (i) signalling events—PENK—narcolepsy	0.00324	0.00379	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide ligand-binding receptors—NPS—narcolepsy	0.0032	0.00375	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.0032	0.00375	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—PENK—narcolepsy	0.00318	0.00372	CbGpPWpGaD
Buprenorphine—ABCG2—midbrain—narcolepsy	0.00317	0.0218	CbGeAlD
Buprenorphine—OPRK1—GPCR ligand binding—HCRTR2—narcolepsy	0.00317	0.00371	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—HCRTR1—narcolepsy	0.00317	0.00371	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—P2RY11—narcolepsy	0.00306	0.00358	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00305	0.00357	CbGpPWpGaD
Buprenorphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00303	0.00354	CbGpPWpGaD
Buprenorphine—OPRD1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00302	0.00354	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—TRH—narcolepsy	0.00298	0.00349	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—HCRT—narcolepsy	0.00297	0.00347	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00296	0.00346	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00289	0.00338	CbGpPWpGaD
Buprenorphine—OPRK1—G alpha (i) signalling events—HRH3—narcolepsy	0.00286	0.00334	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00281	0.00328	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide ligand-binding receptors—NPS—narcolepsy	0.00281	0.00328	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—TRH—narcolepsy	0.00271	0.00317	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.00268	0.00314	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00268	0.00314	CbGpPWpGaD
Buprenorphine—OPRK1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00265	0.0031	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—PENK—narcolepsy	0.00265	0.0031	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—HRH3—narcolepsy	0.00261	0.00306	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—HCRT—narcolepsy	0.0026	0.00305	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00259	0.00303	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00259	0.00303	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—P2RY11—narcolepsy	0.00259	0.00303	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00258	0.00301	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—HCRTR2—narcolepsy	0.00257	0.003	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—HCRTR1—narcolepsy	0.00257	0.003	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00253	0.00296	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—P2RY11—narcolepsy	0.00248	0.0029	CbGpPWpGaD
Buprenorphine—OPRM1—G alpha (i) signalling events—HRH3—narcolepsy	0.00242	0.00283	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—HRH3—narcolepsy	0.00237	0.00278	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00237	0.00278	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—NPS—narcolepsy	0.00237	0.00278	CbGpPWpGaD
Buprenorphine—ABCB1—forebrain—narcolepsy	0.00237	0.0163	CbGeAlD
Buprenorphine—OPRK1—GPCR ligand binding—PENK—narcolepsy	0.00232	0.00272	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR ligand binding—HTR2A—narcolepsy	0.0023	0.0027	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00227	0.00266	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—TRH—narcolepsy	0.00225	0.00263	CbGpPWpGaD
Buprenorphine—OPRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00224	0.00262	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—HCRT—narcolepsy	0.0022	0.00257	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00219	0.00256	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—TAC1—narcolepsy	0.00216	0.00253	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—NPS—narcolepsy	0.00216	0.00253	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00215	0.00251	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00215	0.00251	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—HCRT—narcolepsy	0.00211	0.00247	CbGpPWpGaD
Buprenorphine—CYP2C8—brain—narcolepsy	0.00205	0.0141	CbGeAlD
Buprenorphine—OPRD1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00204	0.00239	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00204	0.00239	CbGpPWpGaD
Buprenorphine—ABCG2—brain—narcolepsy	0.00199	0.0137	CbGeAlD
Buprenorphine—OPRD1—GPCR downstream signaling—P2RY11—narcolepsy	0.00197	0.00231	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—TRH—narcolepsy	0.00197	0.00231	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—HRH3—narcolepsy	0.00197	0.00231	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—NPS—narcolepsy	0.00197	0.0023	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—TAC1—narcolepsy	0.00197	0.0023	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—PENK—narcolepsy	0.00196	0.00229	CbGpPWpGaD
Buprenorphine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.00195	0.00228	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00192	0.00225	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00188	0.0022	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00188	0.0022	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—PENK—narcolepsy	0.00188	0.0022	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—HCRTR1—narcolepsy	0.00186	0.00217	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—HCRTR2—narcolepsy	0.00186	0.00217	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—P2RY11—narcolepsy	0.00179	0.0021	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00179	0.0021	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00179	0.0021	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—P2RY11—narcolepsy	0.00173	0.00202	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—HRH3—narcolepsy	0.00173	0.00202	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.00173	0.00202	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00172	0.00202	CbGpPWpGaD
Buprenorphine—ABCB1—medulla oblongata—narcolepsy	0.00171	0.0118	CbGeAlD
Buprenorphine—OPRD1—GPCR downstream signaling—HCRT—narcolepsy	0.00168	0.00196	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—TRH—narcolepsy	0.00167	0.00195	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—NPS—narcolepsy	0.00164	0.00191	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—TAC1—narcolepsy	0.00164	0.00191	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HCRTR2—narcolepsy	0.00163	0.0019	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HCRTR1—narcolepsy	0.00163	0.0019	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.00162	0.00189	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TRH—narcolepsy	0.0016	0.00187	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00159	0.00186	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00159	0.00186	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—P2RY11—narcolepsy	0.00157	0.00184	CbGpPWpGaD
Buprenorphine—ABCB1—midbrain—narcolepsy	0.00156	0.0108	CbGeAlD
Buprenorphine—OPRD1—Signaling by GPCR—HCRT—narcolepsy	0.00152	0.00178	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00151	0.00177	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00151	0.00177	CbGpPWpGaD
Buprenorphine—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00151	0.00176	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—PENK—narcolepsy	0.0015	0.00175	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—HCRT—narcolepsy	0.00147	0.00172	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.00146	0.00171	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—HRH3—narcolepsy	0.00146	0.00171	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—NPS—narcolepsy	0.00143	0.00168	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—TAC1—narcolepsy	0.00143	0.00168	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—CHKB—narcolepsy	0.00143	0.00167	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—HRH3—narcolepsy	0.0014	0.00164	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00138	0.00161	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00138	0.00161	CbGpPWpGaD
Buprenorphine—CYP2D6—brain—narcolepsy	0.00137	0.00941	CbGeAlD
Buprenorphine—OPRD1—Signaling by GPCR—PENK—narcolepsy	0.00136	0.00159	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HCRT—narcolepsy	0.00134	0.00156	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00133	0.00156	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—P2RY11—narcolepsy	0.00133	0.00155	CbGpPWpGaD
Buprenorphine—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00132	0.00155	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—PENK—narcolepsy	0.00131	0.00153	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—HTR2A—narcolepsy	0.0013	0.00152	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00129	0.00151	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—TRH—narcolepsy	0.00127	0.00149	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00124	0.00146	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.00123	0.00144	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—NPS—narcolepsy	0.00121	0.00142	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—TAC1—narcolepsy	0.00121	0.00142	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00119	0.00139	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—PENK—narcolepsy	0.00119	0.00139	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—HTR2A—narcolepsy	0.00118	0.00138	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TAC1—narcolepsy	0.00116	0.00136	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—NPS—narcolepsy	0.00116	0.00136	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—TRH—narcolepsy	0.00115	0.00135	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00113	0.00133	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HCRT—narcolepsy	0.00113	0.00132	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CHKB—narcolepsy	0.00113	0.00132	CbGpPWpGaD
Buprenorphine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00112	0.00131	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—TRH—narcolepsy	0.00112	0.0013	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—HRH3—narcolepsy	0.00112	0.0013	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—PENK—narcolepsy	0.00111	0.0013	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HCRTR1—narcolepsy	0.0011	0.00128	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HCRTR2—narcolepsy	0.0011	0.00128	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00109	0.00127	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—P2RY11—narcolepsy	0.00106	0.00124	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—TRH—narcolepsy	0.00101	0.00118	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—HRH3—narcolepsy	0.00101	0.00118	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—PENK—narcolepsy	0.00101	0.00118	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—HTR2A—narcolepsy	0.000984	0.00115	CbGpPWpGaD
Buprenorphine—ABCB1—brain—narcolepsy	0.000983	0.00677	CbGeAlD
Buprenorphine—OPRK1—GPCR downstream signaling—HRH3—narcolepsy	0.000978	0.00114	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—CPT1B—narcolepsy	0.00097	0.00114	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HCRTR2—narcolepsy	0.000961	0.00112	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HCRTR1—narcolepsy	0.000961	0.00112	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CHKB—narcolepsy	0.000958	0.00112	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000957	0.00112	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CHKB—narcolepsy	0.000949	0.00111	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—TRH—narcolepsy	0.000942	0.0011	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—P2RY11—narcolepsy	0.000928	0.00109	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000928	0.00109	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—TAC1—narcolepsy	0.000924	0.00108	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—NPS—narcolepsy	0.000924	0.00108	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000907	0.00106	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HCRT—narcolepsy	0.0009	0.00105	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HRH3—narcolepsy	0.000888	0.00104	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CHKB—narcolepsy	0.00087	0.00102	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—HTR2A—narcolepsy	0.000863	0.00101	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—TRH—narcolepsy	0.000856	0.001	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—NPS—narcolepsy	0.000839	0.000982	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—TAC1—narcolepsy	0.000839	0.000982	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—HRH3—narcolepsy	0.000826	0.000967	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HCRTR2—narcolepsy	0.000812	0.00095	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HCRTR1—narcolepsy	0.000812	0.00095	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—TAC1—narcolepsy	0.00081	0.000948	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—NPS—narcolepsy	0.00081	0.000948	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00081	0.000947	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PENK—narcolepsy	0.000802	0.000939	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HCRT—narcolepsy	0.000789	0.000924	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—P2RY11—narcolepsy	0.000785	0.000918	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CPT1B—narcolepsy	0.000767	0.000898	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HRH3—narcolepsy	0.00075	0.000878	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000738	0.000864	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—TAC1—narcolepsy	0.000736	0.000861	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—NPS—narcolepsy	0.000736	0.000861	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—HTR2A—narcolepsy	0.000729	0.000853	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000715	0.000836	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000715	0.000836	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PENK—narcolepsy	0.000704	0.000823	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—HTR2A—narcolepsy	0.000699	0.000817	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CHKB—narcolepsy	0.000686	0.000803	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—TAC1—narcolepsy	0.000685	0.000801	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—NPS—narcolepsy	0.000685	0.000801	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TRH—narcolepsy	0.000682	0.000798	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HCRT—narcolepsy	0.000667	0.000781	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CPT1B—narcolepsy	0.000651	0.000762	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CPT1B—narcolepsy	0.000645	0.000755	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000631	0.000738	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—TAC1—narcolepsy	0.000622	0.000728	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—NPS—narcolepsy	0.000622	0.000728	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HRH3—narcolepsy	0.000598	0.0007	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TRH—narcolepsy	0.000598	0.0007	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PENK—narcolepsy	0.000595	0.000696	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CHKB—narcolepsy	0.000594	0.000695	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CPT1B—narcolepsy	0.000591	0.000692	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—TNF—narcolepsy	0.000581	0.00068	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—HTR2A—narcolepsy	0.000556	0.00065	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CHKB—narcolepsy	0.00053	0.000621	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HRH3—narcolepsy	0.000525	0.000614	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CHKB—narcolepsy	0.000518	0.000606	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TRH—narcolepsy	0.000506	0.000592	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—HTR2A—narcolepsy	0.000505	0.000591	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TAC1—narcolepsy	0.000496	0.00058	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NPS—narcolepsy	0.000496	0.00058	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CHKB—narcolepsy	0.000488	0.000571	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—HTR2A—narcolepsy	0.000487	0.00057	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CHKB—narcolepsy	0.000484	0.000566	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CPT1B—narcolepsy	0.000466	0.000546	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HRH3—narcolepsy	0.000443	0.000519	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HTR2A—narcolepsy	0.000443	0.000518	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TAC1—narcolepsy	0.000435	0.000509	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NPS—narcolepsy	0.000435	0.000509	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CHKB—narcolepsy	0.000413	0.000484	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000412	0.000482	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CPT1B—narcolepsy	0.000404	0.000473	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000374	0.000438	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NPS—narcolepsy	0.000367	0.00043	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TAC1—narcolepsy	0.000367	0.00043	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CPT1B—narcolepsy	0.000361	0.000422	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CPT1B—narcolepsy	0.000352	0.000412	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000332	0.000388	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CPT1B—narcolepsy	0.000329	0.000385	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CHKB—narcolepsy	0.000319	0.000373	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HTR2A—narcolepsy	0.000298	0.000349	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000287	0.000335	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CPT1B—narcolepsy	0.000281	0.000329	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HTR2A—narcolepsy	0.000261	0.000306	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HTR2A—narcolepsy	0.000221	0.000259	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000217	0.000254	CbGpPWpGaD
